Search / Trial NCT00000177

Estrogen Hormone Protocol

Launched by NATIONAL INSTITUTE ON AGING (NIA) · Oct 29, 1999

Trial Information

Current as of October 18, 2024

Completed

Keywords

Alzheimer's Disease Estrogen

Description

No description provided

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • * Women with a diagnosis of Alzheimer's disease who currently are not taking estrogen replacement therapy, who have had a hysterectomy, and who are in stable general health.
  • Exclusion Criteria:
  • * Patients with an uncontrolled health problem, such as untreated high blood pressure or thyroid disease.

About National Institute On Aging (Nia)

The National Institute on Aging (NIA) is a prominent research organization within the National Institutes of Health (NIH) dedicated to advancing our understanding of aging and age-related diseases. Through a robust portfolio of clinical trials, the NIA focuses on innovative research that aims to enhance the health and well-being of older adults. By fostering collaboration among scientists, healthcare professionals, and communities, the NIA seeks to translate research findings into practical solutions that improve the quality of life for aging populations. Their commitment to rigorous scientific inquiry and public health underscores their role as a leader in geriatric research and the pursuit of effective interventions for age-associated conditions.

Locations

Rochester, Minnesota, United States

Baltimore, Maryland, United States

Houston, Texas, United States

Tampa, Florida, United States

Jacksonville, Florida, United States

Atlanta, Georgia, United States

Springfield, Illinois, United States

Kansas City, Kansas, United States

Lexington, Kentucky, United States

Minneapolis, Minnesota, United States

St. Louis, Missouri, United States

New York, New York, United States

Cleveland, Ohio, United States

Philadelphia, Pennsylvania, United States

Pittsburgh, Pennsylvania, United States

Dallas, Texas, United States

Seattle, Washington, United States

Birmingham, Alabama, United States

San Diego, California, United States

Chicago, Illinois, United States

Boston, Massachusetts, United States

White Plains, New York, United States

Indianapolis, Indiana, United States

New York, New York, United States

New York, New York, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0